Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 90100 vs vehicle for psoriasis vulgaris with daily photographic lesion scoring
2020-003929-27Phase 4Active
- Sponsor
- LEO Pharma
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in plaque psoriasis comparing LEO 90100 (Enstilar) with Vehicle (2 arms). Primary endpoint: Change in target lesion score via daily photograph capture. Started Oct 2021; status: active.
02
Drugs
calcipotriol
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2020-003929-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003929-27.